Zhongzhiwei Technology completed tens of millions of yuan financing. On December 12th, Nanjing Zhongzhiwei Information Technology Co., Ltd. (Zhongzhiwei Technology) completed tens of millions of yuan B1 financing, which was jointly invested by Guangzhou Baiyun Financial Holding Group Co., Ltd. and Beijing Hongfeng Private Equity Fund Management Co., Ltd. This round of financing funds will be used for iterative application of AI+ network security products, breakthrough in key industry landing scenarios and market channel construction. Zhongzhiwei Technology is a solution provider of "city-level data+digital security operation", and has launched a series of new platform-based network security products around AISecOps (artificial intelligence security operation).The Bank of Japan's short-term survey may show that business confidence has hardly changed. It is reported that the short-term survey released by the Bank of Japan on Friday may show that the mood of large manufacturers has remained almost unchanged in the last quarter under the influence of complex signals such as the recovery of the automobile industry and concerns about the global economic slowdown. Economists surveyed by data provider Quick predict that the prosperity judgment index of large-scale manufacturing industry will be +12, compared with +13 in the last survey. The survey is closely watched for clues about the decision of the Bank of Japan at its meeting next week. If it shows strong capital expenditure plan, high inflation expectation and tight employment situation, it may support the idea of raising interest rates early.The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)
Zhang Feng, president of Duodianzhi: The retail digital intelligence infrastructure company has developed a number of AI products. On December 12, at the annual partner conference of Duodianzhi in 2024, Zhang Feng, president of Duodianzhi, said that Duodianzhi would always insist on using technology to promote retail development and insist on retail digital intelligence infrastructure. At present, AI technology is booming, and AI will also accelerate the iterative speed of multi-point intelligent systems. In the past year, Duodian has developed a variety of AI products, such as clearing, inspection, etc., and actively practiced and quickly landed, all of which are preparing for the full arrival of the AI era.South Korea's National Election Commission: South Korean President Yin Xiyue's remarks undermined South Korea's electoral system.The OpenAI webpage shows that API, ChatGPT and Sora are all running normally.
In the first ten months, Jiangsu's ship exports exceeded 60%, ranking first in the country. According to Nanjing Customs statistics, from January to October this year, Jiangsu exported 85.84 billion yuan of all kinds of ships, ranking first in the country in terms of export scale, with a year-on-year increase of 63.2%. The exports of three main ship types, namely, tankers, container ships and bulk carriers, increased by 179.5%, 91% and 16.2% respectively.Huadong Pharmaceutical has established a new company in Jiaxing with a registered capital of 60 million yuan. According to Tianyancha App, Huadong Pharmaceutical (Jiaxing) Co., Ltd. was recently established with Zhu Li as its legal representative and a registered capital of 60 million yuan. Its business scope includes drug wholesale, drug retail, decoction service for Chinese herbal pieces, third-class medical device operation, drug Internet information service, drug import and export, third-class medical device rental and medical device Internet information service. According to shareholder information, the company is wholly owned by Huadong Pharmaceutical (000963).Flying Pig: In 2024, the number of holiday businesses whose GMV exceeded 100 million yuan was three times that of last year. On December 12, Flying Pig said at the 2024 holiday business conference that under the positioning of the open platform, the business efficiency and business satisfaction of businesses continued to improve. In 2024, the number of travel agencies, amusement parks, cruise ships and other holiday businesses on the Flying Pig platform maintained double-digit growth year-on-year. The number of businesses with GMV exceeding 100 million yuan was three times that of last year, and the average order volume of gold medal merchants reached more than twice the market level, with a conversion rate about 20% higher.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14